跳至主要内容
临床试验/ACTRN12624000264583
ACTRN12624000264583尚未招募Unknown

A randomised control study evaluating the effect of a yoga program on time to atrial fibrillation recurrence and atrial fibrillation burden in adults with paroxysmal or persistent atrial fibrillation.

Alfred Health0 个研究点目标入组 244 人开始时间: 2024年3月15日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
Alfred Health
入组人数
244

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Disease status: Persons with paroxysmal or persistent AF undertaking a rhythm control strategy who have not undergone an AF ablation in the past 6 months
  • Willingness and ability to given written informed consent and comply with the study protocol
  • Physical ability to undertake Yoga and willing to commit to regular practice for 12 months
  • Medicare eligible Australian residents
  • Internet access

排除标准

  • Regular yoga practice in last 6 months
  • Permanent AF
  • AF ablation in the past 6 months, or likely to undergo AF ablation in the next 6 months
  • The absence of AF lasting >30 seconds in the past 3 months documented by 12-lead electrocardiogram (ECG), ambulatory monitoring or device interrogation
  • Contraindications to yoga such as an inability to participate due to musculoskeletal condition
  • Severe valvular dysfunction
  • Acute myocardial infarction (AMI) or cardiac surgery in preceding 6 months
  • Uncontrolled thyroid disease, autoimmune or systemic inflammatory disease
  • Dementia, cognitive impairment or lack of English language ability to a degree that would impair ability to understand instructions and participate in yoga class
  • Advanced malignancy or other medical condition resulting in life expectancy < 12 months
  • People not eligible for Medicare
  • Unwilling to have an implantable cardiac monitor (ICM) inserted and inability/unwillingness to use Alivecor device or smart watch.

研究者

发起方
Alfred Health

相似试验